Chemours Company, The Earnings

Chemours Company, The’s revenue jumped 5.01% since last year same period to $1615Mn in the Q2 2025. On a quarterly growth basis, Chemours Company, The has generated 18.06% jump in its revenue since last 3-months.

Chemours Company, The’s net profit fell -644.29% since last year same period to $-381Mn in the Q2 2025. On a quarterly growth basis, Chemours Company, The has generated -9425% fall in its net profits since last 3-months.

Chemours Company, The’s net profit margin fell -618.34% since last year same period to -23.59% in the Q2 2025. On a quarterly growth basis, Chemours Company, The has generated -7968.24% fall in its net profit margins since last 3-months.

Chemours Company, The’s earning per share (EPS) estimates for the current quarter stand at 0.24 - a -47.83% fall from last quarter’s estimates.

Chemours Company, The’s earning per share (EPS) estimates for the current year stand at 0.24.

Chemours Company, The’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Chemours Company, The has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Chemours Company, The declared 0.09 dividend per share during the earnings announcement for Q3 2025.